Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 11739835.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The lateral segment of the globus pallidus (GPl) is thought to be overactive in levodopa-induced dyskinesia in PD. Stimulation of cannabinoid receptors in the GPl reduces gamma-aminobutyric acid (GABA) reuptake and enhances GABA transmission and may thus alleviate dyskinesia. In a randomized, double-blind, placebo-controlled, crossover trial (n = 7), the authors demonstrate that the cannabinoid receptor agonist nabilone significantly reduces levodopa-induced dyskinesia in PD.
Medical subject headings
- Dronabinol
- Dyskinesia, Drug-Induced
- Levodopa
- Parkinson Disease
- Receptors, Drug